Björn Albrecht

Partner

Profile

Björn joined McKinsey & Company in 2003 and is a Partner in its Pharmaceutical and Medical Products practice. Björn leads the McKinsey Cancer Center (McKCC), which oversees all of McKinsey’s work on cancer-related topics globally, supporting biotech and pharmaceutical companies, health systems, payors and providers – with the overall aim of making a tangible impact on the lives of cancer patients.

Björn brings a unique combination of scientific background and deep consulting expertise in cancer. Alongside his PhD in molecular oncology (retroviral oncogenesis) from the Comprehensive Cancer Center at The Ohio State University, Björn was a Leukemia & Lymphoma Society post-doctoral fellow at New York University School of Medicine. At McKinsey, Björn has led over 100 engagements on the topic of cancer including over 30 product launches and in-market product accelerations, 20+ cancer business unit and therapeutic area strategies and over 30 cancer research strategies and clinical development plan designs.

Björn founded the McKCC in 2008. The center now undertakes c. 150 client engagements a year covering a broad functional spectrum including marketing and sales, strategy, R&D, Corporate Finance and Business Development, Organisation, Operations and Digital. The McKCC delivers this client service via a large group of experienced colleagues organised in regional hubs on the US East Coast, US West Coast, and in Europe, China, and Japan. Together the team has over 150 years of oncology experience. It is supported by an advisory board of over 20 world-renowned clinician scientists and leaders of professional organisations and advocacy groups, as well as partnerships with expert network providers and a proprietary analytics platform with its own common data models and machine learning capabilities.